Introduction: There is controversy on the optimal work-up of screen-detected widespread breast calcifications: whether to biopsy a single target or multiple targets. This study evaluates agreement between multiple biopsy targets within the same screen-detected widespread (≥25 mm) breast calcification to determine if the second biopsy adds value. Methods: Retrospective observational study of women screened in a statewide general population risk breast cancer mammographic screening program from 2009 to 2016. Screening episodes recalled for widespread calcifications where further views indicated biopsy, and two or more separate target areas were sampled within the same lesion were included. Percentage agreement and Cohen's Kappa were calculated. Results: A total of 293317 women were screened during 761124 separate episodes with recalls for widespread calcifications in 2355 episodes. In 171 women, a second target was biopsied within the same lesion. In 149 (86%) cases, the second target biopsy result agreed with the first biopsy (j = 0.6768). Agreement increased with increasing mammography score (85%, 86% and 92% for score 3, 4 and 5 lesions). Same day multiple biopsied lesions were three times more likely to yield concordant results compared to post-hoc second target biopsy cases. Conclusion: While a single target biopsy is sufficient to discriminate a benign vs. malignant diagnosis in most cases, in 14% there is added value in performing a second target biopsy. Biopsies performed prospectively are more likely to yield concordant results compared to post-hoc second target biopsy cases, suggesting a single prospective biopsy may be sufficient when results are radiological-pathological concordant; discordance still requires repeat sampling.
Introduction
For screen-detected widespread segmental breast calcifications recommended for biopsy in Western Australia there is controversy on the optimal radiological work-up: specifically, is there added value of a second biopsy target within the same lesion. In Western Australia biopsy is recommended for screen-detected breast calcifications that are interpreted on further magnification views as score 3 (possibly malignant), 4 (suspicious for malignancy) or 5 (malignant), a scoring system that overlaps BI-RADs 3/4a, 4b and 4c/5 categories respectively. 1, 2 In the case of widespread continuous or discontinuous but isomorphic screen-detected calcifications, intuitively one expects that a single target should provide a representative sample at histopathology. In the event of radiological-pathological discordance, a repeat biopsy remains indicated, assuming sampling error. 1, 2 In addition, local surgical staging preferences sometimes request biopsyproven malignancy, detected as calcifications, from multiple target sites, with targets >5 cm apart to confirm a widespread transverse or craniocaudal extent of disease as this information is useful in counselling patients who may require extensive surgery (e.g. mastectomy vs. breast conserving surgery). Some radiologists prefer to anticipate this surgical staging request at the time of initial biopsy and prospectively target opposite extents of widespread calcifications, usually anterior/posterior extent on the same day. Some surgeons, however, consider anterior and posterior extent irrelevant, as resection margins dissect to the pectoralis fascia but appreciate transverse or craniocaudal extremes targeted, with two biopsies. In the case of discontinuous calcifications, even if isomorphic, documenting malignancy at two sites is important when counselling women who are motivated to pursue breast conserving surgery. Performing two biopsies on the day of diagnostic imaging workup utilises a second booking slot, thereby delaying access for other scheduled patients. Each additional biopsy target is an additional invasive test that may not be justified.
A recent North American study of 32 cases of only BI-RADS 4 or 5 category continuous segmental calcifications reported 100% histopathological agreement between paired anterior and posterior biopsies of morphologically similar segmental breast calcifications measuring 5 cm or more, suggesting that a second biopsy target to determine extent added no value to a single biopsy target. 3 There is a paucity of literature informing the optimal number of targets to be biopsied in cases of screen-detected, indeterminate, possibly malignant or malignant widespread breast calcification. In particular, for our Australian scoring system, where any calcification interpreted as not definitely benign on magnification views biopsy is indicated (this would include BI-RADS 3 calcifications in a North American setting). We aimed to evaluate in our Western Australian population of screen-detected widespread segmental continuous or discontinuous breast calcifications, that included score 3, 4 or 5, whether we could confirm 100% pathological agreement in biopsy pairs where two or more targets were sampled within the one lesion. We hypothesised that there would be 100% agreement between biopsy pairs, in all cases of screen-detected widespread calcification.
Methods

Study design
We conducted a retrospective observational study of histopathology reports for stereotactic core biopsies performed for widespread segmental continuous or discontinuous breast calcifications in consecutive women screened by BreastScreen WA, a government-funded general population breast screen program in Western Australia. Upon entering the BreastScreen WA screening program, women sign informed consent for information to be used for breast cancer research. Ethics approval was obtained from BreastScreen WA. In addition, institutional Quality Improvement activity approval was obtained which exempted Hospital Research Ethics Committee (HREC) review. Both the BreastScreen WA and WA Metropolitan Health Department Radiology Information System (RIS) databases were queried for women screened between 1 January 2009 and 30 April 2016 where widespread segmental continuous or discontinuous breast calcifications were detected (coded as 'WCA' or 'widespread calcifications') and, after magnification views were performed and biopsy was recommended, two or more biopsy targets were sampled. All widespread discontinuous calcifications were in a segmental distribution and constituted at least three groups of calcifications, no more than 20 mm apart.
Patient selection
BreastScreen WA invites women via the Electoral Roll into a general population risk mammography screening program of biennial mammography between the ages of 50 and 74 years. Women at high risk of breast cancer have annual mammographic screening and women may self-present from age 40 and from age 75, without invitation. Pregnant women are excluded from screening.
Test methods
Screening consisted of bilateral craniocaudal (CC) and mediolateral oblique (MLO) four view digital mammography read in either hard copy or soft copy, as the screening program transitioned to soft copy reporting during the study period, with no change in recall or cancer detection rates. Screening mammogram images were 2D. The assessment centres transitioned to include digital breast tomosynthesis (DBT) for workup of masses, distortions and asymmetries but not for the assessment of calcifications. Routine magnification and true lateral views were performed on all cases recalled for evaluation of screen-detected breast calcifications. Screening mammograms are prospectively double-read by radiologists with subspecialty fellowship training in breast imaging, with reports structured according to the NBCC Synoptic The screening mammograms or further magnification views were validated for study inclusion by one of three Consultant Radiologists (all of whom were authors in this study) for validation of WCA size and morphology.
Data were retrospectively collected from multiple institutions. Biopsies were performed at 14G, 12G or 9G, or a combination, using a Bard Magnum or Suros vacuumassisted device depending on institution but the screening program quality assurance mandates that at least five core samples are taken and specimen radiograph confirms the presence of target calcifications. Histopathology scores were reported according to a pathological five-tier system where score indicated nondiagnostic (1), benign (2), indeterminate/atypical (3), suspicious for malignancy (4) and malignant (5) diagnoses. All pathology results were assessed for radiological-pathological concordance by the reporting radiologists. Histopathology report scores were validated by a single consultant pathologist. Lesions were considered in histopathological agreement if the reported numerical pathology scores' categories matched. Diagnostic pathology scores were also further categorised into binary clinical management categories of 'benign' (return to routine screening) vs. 'not benign' (atypical/suspicious/malignant -requires repeat or excision biopsy or definitive surgery). Lesions were considered in clinical agreement if the binary categorisation of each biopsy matched. Percentage agreement was calculated by dividing the number of paired biopsies in agreement by the total number of paired biopsies for each dataset.
Statistical analysis
Agreement between biopsies was assessed using Cohen's kappa. First, a weighted kappa was calculated for the histopathology scores, which penalised disparate scores progressively as the difference between them increased. Second, kappa was calculated for binary clinical management categories (benign vs. not benign) for each biopsy pair, both for the whole cohort and for specific subgroups. In addition, to investigate the association between clinical agreement and demographic and clinical factors, univariate logistic regression models were fitted to the data. Robust standard error estimates were used to account for the three participants who had two separate encounters with the service for biopsy of different widespread calcifications. P < 0.05 was considered statistically significant and all analyses were conducted using Stata v14.1 (Stata Statistical Software, College Station, TX, USA).
Results
BreastScreen WA conducted 761124 screening episodes for 293317 women between 01 Jan 2009 and 30 April 2016. During this time, there were 2355 recalls for further imaging (magnification views of widespread calcifications), of which 443 were benign and patients were returned to routine screening. In 1912 recalls for WCA, further views were read as indeterminate, suspicious or mammographically malignant and biopsy was recommended. In 1295 of those cases, multiple biopsies were performed. Of those 1295 cases, where two or more biopsies were performed, in 174 cases two or more stereotactic core biopsy targets were performed within a single widespread calcification (Fig. 3) . Other women had biopsies of multiple different lesions.
There were 174 lesions in 171 women that underwent paired biopsies of two or more target areas within the same lesion. The distribution of the two most different (if more than two targets) biopsy results of reported histopathology scores (1 = non-diagnostic, 2 = benign, 3 = indeterminate/atypical, 4 = suspicious for malignancy, 5 = malignant) is displayed in Table 1 . Overall percentage agreement for the 174 lesions biopsied was 79% and 86% for histopathological and clinical agreement, respectively (Table 2) . Of the 174 lesions, 143 paired biopsies were performed prospectively on the same day, while the remaining 31 were performed following a call back following initial biopsy for wider sampling (surgical staging) or radiological-pathological discordance. The latter cases are referred to as post-hoc second target biopsy cases. For the 143 prospective paired biopsies, there was 84% and 89% histopathological and clinical agreement respectively. For post-hoc second target biopsy cases, histopathological agreement was 55% and clinical agreement was 71%.
Of 174 paired biopsies, 94 were performed both with a 14G Bard Magnum biopsy device, 37 were performed with vacuum-assisted devices and four were performed with a combination of the two (Table 3 ). In 39 biopsy pairs, the device used was not recorded. We observed no statistically significant difference in agreement (either histopathological score or clinical assessment) if the biopsy was performed at 14G, or with vacuum assistance (Table 3) . For those biopsies performed with a 14G Bard Magnum biopsy device, there was 77% and 85% histopathological and clinical agreement respectively. For biopsies performed with vacuum assistance, histopathological agreement was 81% and clinical agreement was 84%. Biopsies performed with a combination of devices yielded 50% histopathological and clinical agreement while those where the biopsy device was not stated demonstrated 85% histopathological agreement and 92% clinical agreement. These latter large differences are observed in only four cases and are likely due to chance.
We observed a trend towards increasing percentage agreement with increasing degree of mammography suspicion, with histopathological percentage agreement of 77%, 81% and 85% and clinical agreement of 85%, 86% and 92% for subsets of mammographic scores of 3, 4 and 5 respectively (Table 2) . Lesions measuring 50 mm or larger (n = 104) were in histopathological agreement in 82% of cases and in clinical agreement in 87% of cases (Table 2 ).
Cohen's kappa was calculated to determine if there was agreement between all biopsy pairs (Table 4) . Overall kappa for concordance was 0.68 whether by five-tier histopathology score (CI 0.55-0.81) or binary benignmalignant score (CI 0.53-0.82). However, agreement was never perfect.
Subset analysis (Table 4 ) demonstrated statistically significant agreement between biopsy pairs in WCA measuring 50 mm or more (kappa = 0.6846, CI 0.49-0.88) and in those WCA with a mammography score of 3 (kappa = 0.6902, CI 0.52-0.86). There was only slight agreement between biopsy pairs in those WCA with a mammography score of 4 or 5, which was not statistically significant (kappa = 0.1848, CI À0.09 to 0.46). For prospective biopsy pairs, there was statistically significant agreement between biopsy pairs (kappa = 0.7505, CI 0.59-0.91) while in post-hoc second target biopsy cases, agreement was not statistically significant (kappa = 0.3178, CI À0.03 to 0.67). Table 5 displays the odds ratios from the univariate logistic regression models for clinical agreement. Only biopsy timing was significantly associated with agreement, with prospectively (same day) biopsied patients being over three times more likely to have results in agreement compared to those in the call back group (OR 3.25, P = 0.014). The aforementioned trend towards increasing percentage concordance with increasing degree of mammography suspicion was not statistically significant when analysed for clinical agreement (OR 1.16, P = 0.787 and OR 2.17, P = 0.47). 
Discussion
For screen-detected widespread segmental breast calcifications recommended for biopsy in Western Australia there is controversy on the optimal radiological work-up: specifically, whether there is added value of a second biopsy target within the same lesion. The surgical decision between breast conservation and mastectomy is influenced by several factors, including the extent of disease. Larger lesions of 50 mm or greater require more extensive surgery to achieve clear margins with recurrence largely being influenced by margin status. 4 Anecdotally, it is useful to have histopathological results consistent with mammographic appearances of widespread cancer when counselling women for more aggressive therapy. Our data demonstrate substantial and statistically significant but imperfect agreement between reported histopathology scores obtained from two or more sites within screen-detected widespread continuous or discontinuous calcifications. These results differ from those of Raj et al.
3 who demonstrated 100% agreement between anterior and posterior biopsies in segmental breast calcifications 50 mm or greater. Results of these two studies may differ for a number of reasons. For example, our study included cases between 25 and 50 mm and was not limited to anterior-posterior lesion extent, whilst Raj et al. excluded calcifications <50 mm in size. However, in this study's subgroup of patients with widespread calcifications measuring 50 mm or greater, where the majority had two targets biopsied prospectively at anterior and posterior margins anticipating a surgical staging request, 100% agreement in histopathological result (benign vs.
not benign) was not observed (we observed 87%). This suggests that in up to 13% of cases with clinically divergent results, sampling of multiple sites within widespread calcifications is arguably justifiable. The unexpected finding of only slight agreement between biopsy pairs for mammography scores 4 or 5 can be explained by the smaller sample size of this subset (n = 50) and the inherent greater probability of concordance being due to chance alone. The observed probability of agreement (0.88) is not that much greater than that expected due to chance (0.85), hence kappa is small. In comparison, the probability of agreement due to chance for mammography score 3 lesions (n = 124) was 0.50 and the observed agreement was 0.84. Therefore, although the percentage agreement is equivalent in both groups, the expected agreement is very different and hence, so are the kappa values.
The finding that prospectively biopsied (same day) cases were three times more likely to have results in agreement suggests that performing paired biopsy targets rather than a single biopsy target may not be necessary for screen-detected widespread breast calcifications. The assessment of radiological-pathological concordance (e.g. accept a benign histopathology result) is made at the time of initial biopsy. In three of the 11 post-hoc second biopsy cases recalled for radiologic-pathologic discordance, where a second biopsy target was sampled at a later date, the decision to repeat biopsy was made following second opinion or multidisciplinary meeting. It should be noted that this analysis was exploratory in nature and the sample size for some models was quite small. Therefore, given their potential clinical utility, it is important to demonstrate that these results can be replicated in a larger, prospectively collected, cohort.
The main limitation of this study is its retrospective design, and consequent limited availability of desired data. However, the cases were prospectively enrolled and screened in a statewide program, a population applicable to routine general risk women. Study population heterogeneity limits ability to generalise findings to change program policy. For example, there was heterogeneity in the gauge of biopsy and use of vacuum-assisted techniques and as such the biopsy sensitivity, accuracy and risk of underestimation 5, 6 varied between study population subsets. However, the aim of the study was to identify the presence of cases where paired biopsies within one lesion yielded discordant results, and biopsies performed with or without vacuum assistance showed this. A further study limitation is the potential for selection bias from retrospective study design: not all cases of screen-detected widespread breast calcifications where In conclusion, our data demonstrate statistically significant but imperfect agreement between reported histopathology scores obtained from two or more sites within single screen-detected widespread continuous or discontinuous calcifications (considered single lesions). In 174 lesions in 171 women that underwent paired biopsies the majority (86%) of biopsy pairs were in pathological agreement, with the second biopsy target adding value in 14% of cases, where there was disagreement between biopsy pairs. Our data suggest that the second biopsy target is particularly valuable in cases of radiological-pathological discordance or if the calcifications are interpreted as indeterminate, rather than definitively malignant in appearances. Further research is needed to identify factors that predict cases of pathological disagreement.
